Avara Pharmaceutical Services acquires French facility from AstraZeneca

Avara Pharmaceutical Services has closed on an agreement with AstraZeneca to acquire the latter”™s Reims, France manufacturing and distribution facility.

With the addition of Reims, Avara now has eight sites: three in the U.S., including its corporate headquarters at 101 Merritt 7 in Norwalk, and one each in Puerto Rico, the U.K., Ireland and Italy.

“With rapid expansion and integration set for 2017-2018, we continue, with great confidence, to build a pharmaceutical services company with complementary offerings in key regions to serve the rapidly growing market,” said Avara Chairman and CEO Tim Tyson.

On Sept. 21, Avara signed an agreement with GSK to acquire a GSK consumer health care manufacturing facility in Aiken, South Carolina. The transaction is expected to complete on or before June 1, 2018.